TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›HGYN
HGYN logo

HGYN

HONG YUAN HOLDING GROUP

Next earnings Jul 1, 2026

Buy
$0.04
▲ 0.00%
$0.04▲ +5171.43%
over 1Y
L $0.00H $0.15
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+38.2%
1M-25.9%
3M-67.6%
YTD-2.9%
1Y—
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B-
Valuation
Fair value
Filings
Flagged
Buy
Conviction
Horizon
Medium (3–12mo)

Revenue grew 241.1% YoY.

Revenue (FY2025) $838K · FY2025

HONG YUAN HOLDING GROUP shows $838K in FY2025 revenue (+241.1% YoY), a 18.5% net margin, and -247.6% ROE.

Supporting the case: revenue grew 241.1% YoY; healthy net margin (18.5%); conservative balance sheet (liabilities/equity -9.43x).

Is HGYN a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~60d expiry
  • Long call 0 @ ~0.00 est
  • Short call 0 @ ~0.00 est
debit $0max +$0max $0

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue———$246K$838K
Gross profit———$92.9K$540K
Operating income-$46.3K-$58.3K-$154K-$96.3K$176K
Net income-$46.3K-$58.3K-$154K-$98.8K$155K
Diluted EPS—$0.00$0.00$0.00$0.00
Net margin———-40.3%18.5%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.74M
EV / EBITDA2.6
EV / Sales3.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield5.6%
FCF yield-7.6%

Quality & risk

ROIC (est.)—
Free cash flow-$210K
Total debt—
Net cash$16.7K
Altman Z-Score-218.55 distress
Piotroski F-Score6/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-05-15). Worth a closer look.
  1. 10-Q Quarterly report2026-06-22
  2. NT 10-Q Late filing notice2026-05-15
  3. 10-K Annual report2026-05-08
  4. NT 10-K Late filing notice2026-04-01
  5. 8-K/A Amended 8-K2026-01-13
  6. 8-K Officer / director change2026-01-09
  7. 10-Q Quarterly report2025-11-19
  8. NT 10-Q Late filing notice2025-11-14
  9. 10-Q/A Restated periodic report2025-09-26

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-06-22open ↗NT 10-QPeriod ending 2026-03-312026-05-15open ↗10-KPeriod ending 2025-12-312026-05-08open ↗NT 10-KPeriod ending 2025-12-312026-04-01open ↗8-K/APeriod ending 2025-10-092026-01-13open ↗8-KPeriod ending 2026-01-072026-01-09open ↗10-QPeriod ending 2025-09-302025-11-19open ↗NT 10-QPeriod ending 2025-09-302025-11-14open ↗10-Q/APeriod ending 2025-06-302025-09-26open ↗10-Q/APeriod ending 2025-03-312025-09-26open ↗10-QPeriod ending 2025-06-302025-08-19open ↗NT 10-QPeriod ending 2025-06-302025-08-14open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueB
GrowthA+
ProfitabilityA
Financial healthF
MomentumF
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Liabilities below 2× equity
0.0052-week0.15
Revenue
$838K
+241.1% YoY
Net margin
18.5%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$838K+241.1%
Net income$155K+257.1%
Gross profit$540K+480.9%
Operating income$176K+283.3%
Diluted EPS$0.00
Cash & equivalents$16.7K-56.5%
Total assets$611K+174.5%
Total liabilities$592K+51.1%
Stockholders' equity-$62.7K+72.9%
Gross: 64.4%Op.: 21.1%L/E: -9.43x

Frequently asked

Is HONG YUAN HOLDING GROUP (HGYN) a buy?
HGYN currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Revenue grew 241.1% YoY.
What is HONG YUAN HOLDING GROUP's quality score?
HGYN scores 67.66633333333334/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001324759, latest 10-Q filed 2026-06-22) · EODHD · as of 6/22/2026, 9:47:31 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 22, 2026, 5:47 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2012-03-16
Okamoto Kelvin T
Chief Technology Officer
Award9.62K
2012-03-16
Okada Michael
see remarks
Award9.62K
2012-03-16
Barton Mark
Sr. V.P. - Manufacturing
Award8.65K
2011-12-16
Sheehan Heather E
S.V.P., CFO
Buy2.35K
2011-12-05
SCHEER FREDERIC
CEO
Buy2.08K @ $1.15$2.39K
2011-11-30
SCHEER FREDERIC
CEO
Buy2.11K @ $1.14$2.41K
2011-11-28
SCHEER FREDERIC
CEO
Buy2.36K @ $1.01$2.38K

Earnings history

beat/miss · move
2013-04-19——8-K ↗
2013-04-19——8-K ↗
2012-05-15Miss -15.9% est—8-K ↗
2012-04-16Miss -15.9% est—8-K ↗
2011-11-15Miss -50.3% est—8-K ↗
2011-11-07Miss -50.3% est—8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score68 vs 67
Revenue growth241.1% vs 7.5%
Net margin18.5% vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2